logo

Gilead Sciences Inc. (GILD)



Trade GILD now with
  Date
  Headline
11/29/2022 8:34:19 AM Gilead : EC Grants Expanded Marketing Authorization For Biktarvy For Treatment Of HIV In Pediatric Populations
11/28/2022 8:47:30 AM Gilead, Arcus Announce Update On Joint TIGIT Program From Interim Analysis Of ARC-7 Study In Non-Small Cell Lung Cancer
10/27/2022 6:21:36 PM Gilead Sciences Inc. (GILD) Has Raised Its 2022 EPS Estimate To 6.95 - 7.15 From 6.35 - 6.75
10/27/2022 4:58:46 PM Gilead Sciences Q3 EPS $1.42 Vs. $2.05 Year Ago
10/24/2022 2:11:37 AM Gilead Presents Real-World Evidence Reinforcing Use Of Biktarvy For Treatment Of HIV With Range Of Comorbidities
10/17/2022 7:33:05 AM Gilead Sciences, MacroGenics Announce Oncology Collaboration To Develop Bispecific Antibodies
10/11/2022 8:33:39 AM Gilead Sciences: FDA Accepts For Priority Review SBLA For Trodelvy For Pre-Treated HR+/HER2- Metastatic Breast Cancer
10/3/2022 9:05:21 AM Gilead : FDA Oks Kite's Viral Vector Manufacturing Facility In Southern California To Produce Commercial Product